Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Genomic Instability and MYC[original query] |
|---|
| Proto-oncogene amplification and overexpression in cadmium-induced cell transformation. Journal of toxicology and environmental health. Part A 2003 1 65 (24): 2131-44. Spruill M D, Song B, Whong W-Z, Ong |
| ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers. Genes, chromosomes & cancer 2004 Sep 41 (1): 1-11. Adem Camilo, Soderberg Cheryl L, Hafner Kari, Reynolds Carol, Slezak Jeffrey M, Sinclair Colleen S, Sellers Thomas A, Schaid Daniel J, Couch Fergus, Hartmann Lynn C, Jenkins Robert |
| Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients. Genes, chromosomes & cancer 2017 Nov . Oltmann Johanna, Heselmeyer-Haddad Kerstin, Hernandez Leanora S, Meyer Rüdiger, Torres Irianna, Hu Yue, Doberstein Natalie, Killian J Keith, Petersen David, Zhu Yuelin Jack, Edelman Daniel C, Meltzer Paul S, Schwartz Russell, Gertz E Michael, Schäffer Alejandro A, Auer Gert, Habermann Jens K, Ried Thom |
| Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood 2018 6 132 (6): 587-597. Walker Brian A, Mavrommatis Konstantinos, Wardell Christopher P, Ashby T Cody, Bauer Michael, Davies Faith E, Rosenthal Adam, Wang Hongwei, Qu Pingping, Hoering Antje, Samur Mehmet, Towfic Fadi, Ortiz Maria, Flynt Erin, Yu Zhinuan, Yang Zhihong, Rozelle Dan, Obenauer John, Trotter Matthew, Auclair Daniel, Keats Jonathan, Bolli Niccolo, Fulciniti Mariateresa, Szalat Raphael, Moreau Philippe, Durie Brian, Stewart A Keith, Goldschmidt Hartmut, Raab Marc S, Einsele Hermann, Sonneveld Pieter, San Miguel Jesus, Lonial Sagar, Jackson Graham H, Anderson Kenneth C, Avet-Loiseau Herve, Munshi Nikhil, Thakurta Anjan, Morgan Gareth |
| Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations. BMC cancer 2018 01 18 (1): 8. Böttcher René, Kweldam Charlotte F, Livingstone Julie, Lalonde Emilie, Yamaguchi Takafumi N, Huang Vincent, Yousif Fouad, Fraser Michael, Bristow Robert G, van der Kwast Theodorus, Boutros Paul C, Jenster Guido, van Leenders Geert J L |
| Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma. JCI insight 2019 5 4 (13): . Lee Chang-Lung, Mowery Yvonne M, Daniel Andrea R, Zhang Dadong, Sibley Alexander B, Delaney Joe R, Wisdom Amy J, Qin Xiaodi, Wang Xi, Caraballo Isibel, Gresham Jeremy, Luo Lixia, Van Mater David, Owzar Kouros, Kirsch David |
| Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies. Cancer reports (Hoboken, N.J.) 2020 Jul e1267. Naderi A |
| High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer Patients. The American journal of pathology 2020 May . Koçak Ayla, Heselmeyer-Haddad Kerstin, Lischka Annette, Hirsch Daniela, Fiedler David, Hu Yue, Doberstein Natalie, Torres Irianna, Chen Wei-Dong, Gertz E Michael, Schäffer Alejandro A, Freitag-Wolf Sandra, Kirfel Jutta, Auer Gert, Habermann Jens K, Ried Thom |
| Distinct Genomic Alterations in Prostate Tumors Derived from African American Men. Molecular cancer research : MCR 2020 10 18 (12): 1815-1824. Liu Wennuan, Zheng S Lilly, Na Rong, Wei Lin, Sun Jishan, Gallagher Johnie, Wei Jun, Resurreccion W Kyle, Ernst Sarah, Sfanos Karen S, Isaacs William B, Xu Jianfe |
| Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse. Nature communications 2021 Oct 12 (1): 6248. Fraser Michael, Livingstone Julie, Wrana Jeffrey L, Finelli Antonio, He Housheng Hansen, van der Kwast Theodorus, Zlotta Alexandre R, Bristow Robert G, Boutros Paul |
| Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P). BMC medicine 2022 7 20 (1): 237. Zhu Sha, Zhao Jinge, Nie Ling, Yin Wenlian, Zhang Yaowen, Zhao Fengnian, Ni Yuchao, Zhang Xingming, Wang Zhipeng, Dai Jindong, Liu Zhenhua, Chen Junru, Zeng Yuhao, Wang Zilin, Sun Guangxi, Liang Jiayu, Zhao Xiaochen, Zhu Xudong, Tao Ronggui, Yang Jiyu, He Ben, Chen Ni, Shen Pengfei, Zeng H |
| Inferring Homologous Recombination Deficiency of Ovarian Cancer From the Landscape of Copy Number Variation at Subchromosomal and Genetic Resolutions. Frontiers in oncology 2022 1 11 772604. Zhang Meng, Ma Si-Cong, Tan Jia-Le, Wang Jian, Bai Xue, Dong Zhong-Yi, Zhang Qing-X |
- Page last reviewed:Feb 1, 2024
- Content source: